BridgeBio have demonstrably boosted the progress of a new treatment for amyloid heart disease, utilizing the compound. Preliminary patient results reveals potential improvements for those suffering from the severe https://biotech194335.dgbloggers.com/42552871/company-progresses-cardiac-amyloidosis-management-through-the-drug